SG Americas Securities’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.77M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8.6M | Buy |
|
|||||
|
2024
Q4 | $407K | Sell |
|
|||||
|
2024
Q3 | $684K | Sell |
|
|||||
|
2024
Q2 | $653K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $440K | Sell |
|
|||||
|
2023
Q3 | $433K | Buy |
|
|||||
|
2023
Q2 | $114K | Sell |
|
|||||
|
2023
Q1 | $982K | Buy |
|
|||||
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $1.35M | Buy |
|
|||||
|
2021
Q4 | $152K | Sell |
|
|||||
|
2021
Q3 | $180K | Sell |
|
|||||
|
2021
Q2 | $13.1M | Buy |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $447K | Sell |
|
|||||
|
2020
Q3 | $344K | Buy |
|
|||||
|
2020
Q2 | $314K | Sell |
|
|||||
|
2020
Q1 | $578K | Sell |
|
|||||
|
2019
Q4 | $647K | Sell |
|
|||||
|
2019
Q3 | $833K | Buy |
|
|||||
|
2019
Q2 | $434K | Sell |
|
|||||
|
2019
Q1 | $12.6M | Buy |
|
|||||
|
2018
Q4 | $274K | Buy |
|
|||||
|
2018
Q3 | $115K | Sell |
|
|||||
|
2018
Q2 | $214K | Sell |
|
|||||
|
2018
Q1 | $175K | Buy |
|
|||||
|
2017
Q4 | $145K | Buy |
|
|||||
|
2017
Q3 | $156K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $880K | Buy |
|
|||||
|
2016
Q3 | $782K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $379K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $430K | Buy |
|
|||||
|
2015
Q2 | $146K | Sell |
|
|||||
|
2015
Q1 | $246K | Sell |
|
|||||
|
2014
Q4 | $201K | Buy |
|
|||||
|
2014
Q3 | $138K | Buy |
|